PARIS: French healthcare group Sanofi, along with its business partner, has asked the European Medicines Agency (EMA) to review the fexinidazole product for the treatment of sleeping sickness, the company said on Wednesday. Fexinidazole is being developed in collaboration with the Drugs for ...